Gamma interferon formulation

Details Gamma interferon formulation Gamma interferon formulation

1990-04-25

1992-09-29

Wax, Robert A.

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

530351, 435 6951, A61K 3766, C07K 1300

Patent

active

051512653

ABSTRACT:
A liquid pharmaceutical composition comprising an effective amount of non-lyophilized gamma-interferon. The liquid pharmaceutical composition which additionally includes a buffer capable of maintaining the pH of the liquid composition within the range of 4.0 to 6.0, a stabilizing agent and a non-ionic detergent.

REFERENCES:
patent: 4100150 (1978-07-01), Cartwright et al.
patent: 4469228 (1984-09-01), Zupon et al.
patent: 4483849 (1984-11-01), Carter et al.
patent: 4496537 (1985-01-01), Kwan et al.
patent: 4647454 (1987-03-01), Cymbalista et al.
patent: 4659570 (1987-04-01), Terano et al.
patent: 4675184 (1987-06-01), Hasegawa et al.
patent: 4714611 (1987-12-01), Tetsuo et al.
patent: 4751078 (1988-06-01), Nagabhushan et al.
patent: 4824674 (1989-04-01), Becker et al.
patent: 4847079 (1989-07-01), Kwan et al.
patent: 4911908 (1990-03-01), Estis et al.
Wang et al., (1988) Journal of Parental Science & Technology, vol. 42, 54-526.
Blalock et al., Cellular Immunology 49, 390-394 (1980).
Patent Abstracts of Japan, vol. 9, No. 28 (C-264)[1751] Feb. 6, 1985.
Patent Abstracts of Japan, vol. 11, No. 139 (C-420)[2586] May 7, 1987.
Sedmak et al., Biol. Med. 41, 274-279 (1981) (Abstract Only).

Affiliated with

Also associated with

Rating

Gamma interferon formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gamma interferon formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma interferon formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1967053